Computational Study Uncovers How New Peptides Activate Ghrelin Receptor

The ghrelin receptor (also known as the growth hormone secretagogue receptor 1a or GHSR1a) plays a crucial role in regulating appetite, metabolism, and growth hormone release. Agonists of this receptor hold promise for treating conditions like cachexia (muscle wasting) or growth hormone deficiency. While a novel family of peptides has been identified as ghrelin receptor agonists, the precise molecular mechanisms and binding interactions at the receptor level remained largely unknown.

The computational analysis successfully elucidated detailed binding modes for the novel peptide family within the GHSR1a receptor. They identified specific hydrogen bonds and hydrophobic interactions between the peptides and key residues in the receptor's binding site, such as Trp276 and Phe282. These interactions are predicted to stabilize the active conformation of the receptor, explaining their agonistic properties. The study predicted that these peptides primarily interact with the transmembrane helices TM3, TM5, and TM6 of the GHSR1a receptor, forming a stable complex crucial for receptor activation. Furthermore, the simulations suggested that subtle structural differences among the peptides within the family led to distinct, yet functionally similar, binding poses, all contributing to effective receptor activation. This detailed molecular mapping provides a blueprint for understanding their efficacy.